KOR
ENG
ABOUT US
Greeting
Vision
History
People
TECHNOLOGY
Cell-Fusion
miRNA
PIPELINE
CAREERS
PR
Press release
Promotion
Notice
PR
PR
ABOUT US
TECHNOLOGY
PIPELINE
CAREERS
PR
Press release
Press release
Promotion
Notice
MaxCyte Signs Strategic Platform License with Curamys to Enable Cell & Gene Therapies for the Treatment of Rare Intractable Diseases
2022.12.05
"We will overcome intractable Lou Gehrig's disease & Duchenne disease."
2020.01.22
TOP
TOP
info@curamys.com
TOP
info@curamys.com